The University of Kansas Medical Center, Division of Hematology and Oncology in the Department of Internal Medicine offers a three-year combined fellowship program accredited through the Accreditation Council for Graduate Medical Education. This program, when completed successfully, provides board eligibility in both Hematology and Medical Oncology. The University is affiliated with the Kansas City Veterans Affairs Medical Center. Fellows spend one fourth to one third of their time at the VA during the fellowship program.
The Fellowship Program includes activities in both the outpatient and inpatient settings. Emphasis is placed on outpatient care and continuity of care in an interactive multidisciplinary environment. Fellows are placed in a Hematology and an Oncology continuity clinic that allows them to follow specific patients for 3 years. They also rotate through other clinics. Fellows receive exposure to an active Bone Marrow Transplant Program, including autologous, allogeneic and unrelated transplants in addition to a large Breast Cancer Prevention Program.
A portion of time is spent on electives, which include radiation therapy, blood banking, palliative care, research and other subspecialty areas. All fellows are expected to participate in research projects and write two papers.
We are a member and participant of the Southwest Oncology Group, a large national cooperative clinical trials group, the RTOG, and have grants in prevention trials and phase I-II agents as well. Our faculty research interests are very diversified. These research interests include, but are not limited to, new agents, combined radiation and chemotherapy trials, thrombotic disorders, and prevention trials. Please see the GME manual section 5.8.3 for a detail outline of our work environment expectations.
Sarah A. Taylor, M.D.
Professor of Medicine
Director, Hematology/Oncology Fellowship Program